Top Markets
Coin of the day
Inari Medical, Inc. Inari Medical, Inc.

Inari Medical, Inc.

NARI
株式のランク #3846
Inari Medical, Inc. is a medical technology firm focused on creating,... Inari Medical, Inc. is a medical technology firm focused on creating, producing, promoting, and distributing devices for the minimally invasive management of venous conditions within the United States. Their product portfolio includes ClotTriever, a mechanical thrombectomy solution designed to extract significant clots from major blood vessels, specifically targeting deep vein thrombosis. Another key offering is FlowTriever, a substantial catheter-based aspiration and mechanical thrombectomy system, which addresses pulmonary embolism. The company also provides FlowSaver; FlowStasis, a large-bore suture retention device to manage venous access points; and FlowTriever 2, an enhanced version with a new disk design for efficiently capturing wall-adherent clots and reducing procedure time. Founded in 2011, the company was initially known as Inceptus Newco1 Inc. before rebranding as Inari Medical, Inc. in September 2013. Its corporate headquarters are located in Irvine, California.
株価
$79.97
最終同期: 2025-02-19
時価総額
$4.57B
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Inari Medical, Inc. (NARI)

カテゴリー

Inari Medical, Inc.(NARI)の営業利益率
August 2026 時点の営業利益率 TTM: -2.84%
Inari Medical, Inc. の最新の財務報告と株価によると、現在の営業利益率(TTM)は -2.84% です。2022 年末時点では -7.33% でした。
Inari Medical, Inc. の営業利益率の履歴(2018 から 2026)
各年末の営業利益率
営業利益率 変化
2026 (TTM) -2.84% 0.00%
2023 -2.84% -61.26%
2022 -7.33% -404.15%
2021 2.41% -81.73%
2020 13.19% 740.13%
2019 1.57% -101.17%
2018 -133.84% 0.00%
同業他社の営業利益率
企業 営業利益率 営業利益率の差
17.03% -106.00%
US
22.03% -107.76%
US
17.86% -106.29%
IE
21.46% -107.56%
US
0.00% -
DE
企業の営業利益率とは?
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。